BSE Live
Nov 07, 16:01Prev. Close
442.10
Open Price
441.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 07, 15:55Prev. Close
441.75
Open Price
436.65
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Venus Remedies (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 33.90 | 21.31 | 19.88 | 30.86 | 50.04 | |
| Diluted EPS (Rs.) | 33.90 | 21.31 | 19.88 | 30.86 | 50.04 | |
| Cash EPS (Rs.) | 50.74 | 41.10 | 44.04 | 55.55 | 78.63 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 419.65 | 364.74 | 344.38 | 329.50 | 324.33 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 419.65 | 364.74 | 344.38 | 329.50 | 324.33 | |
| Revenue from Operations/Share (Rs.) | 484.69 | 449.95 | 415.58 | 447.86 | 444.11 | |
| PBDIT/Share (Rs.) | 63.20 | 53.25 | 52.76 | 52.68 | 59.48 | |
| PBIT/Share (Rs.) | 46.37 | 33.47 | 28.60 | 27.60 | 30.90 | |
| PBT/Share (Rs.) | 53.73 | 33.40 | 28.38 | 27.24 | 39.34 | |
| Net Profit/Share (Rs.) | 33.90 | 21.31 | 19.87 | 30.47 | 50.04 | |
| NP After MI And SOA / Share (Rs.) | 33.90 | 21.31 | 19.87 | 30.47 | 50.04 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 13.04 | 11.83 | 12.69 | 11.76 | 13.39 | |
| PBIT Margin (%) | 9.56 | 7.43 | 6.88 | 6.16 | 6.95 | |
| PBT Margin (%) | 11.08 | 7.42 | 6.82 | 6.08 | 8.85 | |
| Net Profit Margin (%) | 6.99 | 4.73 | 4.78 | 6.80 | 11.26 | |
| NP After MI And SOA Margin (%) | 6.99 | 4.73 | 4.78 | 6.80 | 11.26 | |
| Return on Networth/Equity (%) | 8.07 | 5.84 | 5.77 | 9.24 | 15.43 | |
| Return on Capital Employed (%) | 10.69 | 8.17 | 7.37 | 7.57 | 8.31 | |
| Return on Assets (%) | 6.33 | 4.54 | 4.41 | 7.02 | 11.11 | |
| Total Debt/Equity (X) | 0.00 | 0.08 | 0.09 | 0.10 | 0.13 | |
| Asset Turnover Ratio (%) | 0.97 | 0.98 | 0.90 | 1.01 | 98.60 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.31 | 4.53 | 3.91 | 3.00 | 2.38 | |
| Quick Ratio (X) | 2.58 | 2.99 | 2.46 | 1.64 | 1.15 | |
| Inventory Turnover Ratio (X) | 5.83 | 2.85 | 2.65 | 3.04 | 4.57 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 1,291.82 | 759.66 | 239.55 | 146.41 | 2.93 | |
| Interest Coverage Ratios (Post Tax) (%) | 1,291.82 | 759.66 | 239.55 | 146.41 | 2.93 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 322.06 | 409.53 | 205.06 | 351.82 | 361.07 | |
| EV/Net Operating Revenue (X) | 0.50 | 0.68 | 0.37 | 0.59 | 0.66 | |
| EV/EBITDA (X) | 3.81 | 5.75 | 2.91 | 5.00 | 4.92 | |
| MarketCap/Net Operating Revenue (X) | 0.62 | 0.73 | 0.39 | 0.60 | 0.62 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 0.71 | 0.89 | 0.47 | 0.82 | 0.85 | |
| Price/Net Operating Revenue | 0.62 | 0.73 | 0.39 | 0.60 | 0.62 | |
| Earnings Yield | 0.11 | 0.07 | 0.12 | 0.11 | 0.18 |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y